Ticker,Title,Link
TGTX,Maintaining Hold on TG Therapeutics Amidst Positive Performance and Ongoing Uncertainties,8/6/2024 8:45:48 PM
TGTX,TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update,8/5/2024 1:30:00 PM
TGTX,TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference,6/7/2024 1:50:00 PM
TGTX,TG Therapeutics to Participate in the Jefferies Global Healthcare Conference,6/3/2024 1:30:00 PM
TGTX,TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting,5/31/2024 1:30:00 PM
TGTX,TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting,5/28/2024 1:30:00 PM
TGTX,"Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",5/25/2024 2:24:03 PM
TGTX,"Catalyst Watch: Retail heavyweights Walmart and Home Depot report, OpenAI vs. Google, and EV tariff drama",5/10/2024 7:00:11 PM
TGTX,Sell Rating on TG Therapeutics: Caution Amid Competitive Threats and Decelerating Prescription Growth,5/2/2024 9:25:27 AM
TGTX,Hold Rating on TG Therapeutics Amidst Strong Briumvi Launch and Competitive Market Pressures,5/1/2024 9:35:22 PM
TGTX,TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update,4/30/2024 10:55:29 PM
TGTX,Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX),4/23/2024 1:38:45 PM
TGTX,TG Therapeutics wins VA contract for Briumvi,4/18/2024 5:15:50 PM
TGTX,TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting,4/15/2024 1:30:00 PM
TGTX,TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting,3/8/2024 1:30:00 PM
TGTX,TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum,3/1/2024 1:30:00 PM
TGTX,TG Therapeutics: A Strong Buy on Robust Briumvi Sales and Promising Pipeline Prospects,2/29/2024 12:45:48 PM
TGTX,Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,2/28/2024 8:02:03 PM
TGTX,TG Therapeutics Q4 2023 Earnings Preview,2/27/2024 6:23:14 PM
TGTX,TG Therapeutics: Promising European Expansion and Strong Financial Outlook Justify Buy Rating,2/26/2024 4:45:20 PM
TGTX,TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update,2/23/2024 1:30:00 PM
TGTX,"PTON, PLUG, and CAR are some of the high beta losers to Sell according to Oppenheimer",2/20/2024 6:11:04 PM
TGTX,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Zoetis (ZTS) and Teladoc (TDOC)",2/13/2024 2:02:19 PM
TGTX,Buy Rating Affirmed for TG Therapeutics on Strong Briumvi Sales and Favorable Market Dynamics,2/2/2024 5:45:28 PM
TGTX,7 Exciting Stocks Poised for Explosive Growth in Key Sectors,1/22/2024 11:30:00 AM
TGTX,HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know,1/11/2024 6:00:39 PM
TGTX,Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,1/10/2024 7:06:19 PM
TGTX,TG Therapeutics Acquires Worldwide License Agreement For Precision's Cell Therapy Program ,1/9/2024 8:14:54 PM
TGTX,TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference,1/5/2024 1:30:00 PM
TGTX,Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,12/6/2023 8:43:03 PM
TGTX,TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference,11/27/2023 1:30:00 PM
TGTX,Robust Financial Performance and Promising Sales Trajectory Drive Edward White’s Buy Rating for TG Therapeutics,11/2/2023 6:57:23 PM
TGTX,Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged,11/1/2023 7:33:23 PM
TGTX,TG Therapeutics earnings preview: what Wall Street is expecting,10/31/2023 3:01:13 PM
TGTX,"Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday",10/30/2023 3:19:29 PM
TGTX,"General Electric, Verizon, Cleveland-Cliffs And Other Big Stocks Moving Higher On Tuesday",10/24/2023 5:40:50 PM
TGTX,Analyst Expectations for TG Therapeutics's Future,10/20/2023 8:00:45 PM
TGTX,"TG Therapeutics Stock: A Buy Amid Market Volatility, Potential Growth and Promising Data",10/19/2023 2:16:22 PM
TGTX,"Analysts Conflicted on These Healthcare Names: Nurix Therapeutics (NRIX), Tarsus Pharmaceuticals (TARS) and TG Therapeutics (TGTX)",10/16/2023 10:31:47 AM
TGTX,Promising Clinical Trial Results and Market Potential Propel TG Therapeutics’ Buy Rating,10/11/2023 4:35:39 PM
TGTX,"Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday",9/29/2023 4:58:28 PM
TGTX,"Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT), TG Therapeutics (TGTX) and Harpoon Therapeutics (HARP)",9/18/2023 10:20:17 AM
TGTX,"Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX) and Mineralys Therapeutics, Inc. (MLYS)",9/11/2023 9:31:13 AM
TGTX,TG Therapeutics falls as Cantor tracks latest Briumvi sales data,9/8/2023 2:26:41 PM
TGTX,3 Very Oversold Biotech Stocks to Buy Right Now,8/29/2023 4:43:00 AM
TGTX,TG Therapeutics spikes as CEO buys $1M shares,8/14/2023 5:25:07 PM
TGTX,"TGTX, NKTR and AMLI among pre-market losers",8/11/2023 12:16:36 PM
TGTX,"Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023",8/2/2023 5:00:31 PM
TGTX,Dow Gains Over 50 Points; Caterpillar Earnings Top Expectations,8/1/2023 9:21:50 PM
TGTX,TG Therapeutics (TGTX) Gets a Sell from Bank of America Securities,7/28/2023 10:25:41 AM
TGTX,Analyst Ratings for TG Therapeutics,7/24/2023 5:00:35 PM
TGTX,Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX) and Elanco Animal Health (ELAN),7/14/2023 9:10:15 AM
TGTX,Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,7/13/2023 6:49:22 PM
TGTX,"Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Bayer (OtherBAYRY) and United Therapeutics (UTHR)",7/10/2023 12:11:25 PM
TGTX,Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session,7/7/2023 6:55:51 PM
TGTX,TG Therapeutics started at buy at Jefferies on MS asset Briumvi,6/26/2023 3:58:05 PM
TGTX,B.Riley Financial Sticks to Its Buy Rating for TG Therapeutics (TGTX),6/2/2023 2:45:08 PM
TGTX,TG Therapeutics granted EU nod for multiple sclerosis therapy Briumvi,6/1/2023 1:59:46 PM
TGTX,Analyst Expectations for TG Therapeutics's Future,5/31/2023 8:00:56 PM
TGTX,B.Riley Financial Remains a Buy on TG Therapeutics (TGTX),5/17/2023 12:05:37 PM
TGTX,"Analysts Have Conflicting Sentiments on These Healthcare Companies: TG Therapeutics (TGTX), Sarepta Therapeutics (SRPT) and Inmune Bio (INMB)",5/14/2023 1:41:09 PM
TGTX,"TGTX, TCRX and DRMA are among pre-market gainers",5/10/2023 12:19:32 PM
TGTX,TG Therapeutics (TGTX) Receives a Buy from B.Riley Financial,5/1/2023 9:05:05 PM
TGTX,Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April,4/30/2023 4:01:31 PM
TGTX,TG Therapeutics gains after reimbursement win for multiple sclerosis therapy,4/27/2023 5:40:17 PM
TGTX,Did You Catch These Biotech High-Flyers Before They Hit New Highs Yesterday? ,4/26/2023 9:56:40 AM
TGTX,Where TG Therapeutics Stands With Analysts,4/17/2023 5:00:50 PM
TGTX,H.C. Wainwright Keeps Their Buy Rating on TG Therapeutics (TGTX),4/14/2023 2:45:06 PM
TGTX,Get In Now. 7 Stocks That Are Set to Soar.,4/13/2023 7:49:06 PM
TGTX,Goldman Sachs Keeps Their Sell Rating on TG Therapeutics (TGTX),4/11/2023 11:15:12 PM
TGTX,Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI) and TG Therapeutics (TGTX),4/10/2023 11:40:32 PM
TGTX,Analyst Ratings for TG Therapeutics,3/31/2023 8:00:35 PM
TGTX,Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session,3/10/2023 6:58:38 PM
TGTX,TG Therapeutics’ price for multiple sclerosis therapy is not low enough - ICER,3/9/2023 8:42:20 PM
TGTX,"Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Insmed (INSM) and TG Therapeutics (TGTX)",3/3/2023 12:10:33 PM
TGTX,Where TG Therapeutics Stands With Analysts,3/1/2023 7:05:19 PM
TGTX,TG Therapeutics (TGTX) Gets a Buy from B.Riley Financial,2/28/2023 5:35:05 PM
TGTX,TG Therapeutics Q4 2022 Earnings Preview,2/27/2023 10:55:08 PM
TGTX,"Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), DaVita (DVA) and Travere Therapeutics (TVTX)",2/24/2023 10:50:31 AM
TGTX,Top 5 Health Care Stocks That May Collapse In February,2/13/2023 1:14:33 PM
TGTX,TG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapy,2/7/2023 2:13:53 PM
TGTX,B.Riley Financial Keeps Their Buy Rating on TG Therapeutics (TGTX),2/2/2023 5:05:05 PM
TGTX,Immunic adds 14% as Wedbush initiates with bullish view on lead asset,1/31/2023 6:29:59 PM
TGTX,B.Riley Financial Remains a Buy on TG Therapeutics (TGTX),1/26/2023 4:15:07 PM
TGTX,TG Therapeutics stock adds over 10% to reach one-year high,1/24/2023 8:31:37 PM
TGTX,TG Therapeutics adds 10% to extend gains after insider purchase,1/11/2023 5:37:34 PM
TGTX,"EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?",1/4/2023 12:54:34 AM
TGTX,Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket,1/3/2023 1:55:25 PM
TGTX,Analyst Ratings for TG Therapeutics,12/30/2022 4:02:27 PM
TGTX,"Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets",12/29/2022 8:47:40 PM
TGTX,Here's Why TG Therapeutics (TGTX) Shares Are Skyrocketing,12/28/2022 8:13:08 PM
TGTX,"Catalyst watch: Nio event, Ivanhoe Electric lockup expiration and Cal-Maine earnings",12/23/2022 6:30:25 PM
TGTX,"It's almost 2023, but here are the drugs the FDA could approve before the end of the year",12/17/2022 9:00:00 PM
TGTX,Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session,12/16/2022 7:47:01 PM
TGTX,2 Biotech Stocks Under $10 That Could Win From Key FDA Approvals,12/9/2022 2:35:27 AM
TGTX,"Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors",12/2/2022 12:01:03 PM
TGTX,Biotech Stocks Facing FDA Decision In December 2022 ,11/28/2022 6:38:51 AM
TGTX,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), TG Therapeutics (TGTX) and Gossamer Bio (GOSS)",11/14/2022 12:10:54 PM
TGTX,Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday,11/11/2022 11:10:24 AM
TGTX,"Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher",11/10/2022 8:43:48 PM
TGTX,TG Therapeutics is about to announce its earnings — here's what to expect,11/9/2022 3:01:13 PM
TGTX,H.C. Wainwright Reaffirms Their Buy Rating on TG Therapeutics (TGTX),10/13/2022 2:45:09 PM
TGTX,"TGTX DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action - TGTX",9/16/2022 4:42:00 AM
TGTX,"ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX",9/9/2022 4:19:00 AM
TGTX,"ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX",9/2/2022 12:37:00 AM
TGTX,"ROSEN, LEADING INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX",8/26/2022 2:56:00 AM
TGTX,TG Therapeutics Touts Encouraging Data From Multiple Sclerosis Candidate,8/25/2022 6:32:51 PM
TGTX,"ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTX",8/16/2022 4:15:00 AM
TGTX,Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday,8/9/2022 9:24:11 AM
TGTX,"Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session",8/8/2022 6:49:51 PM
TGTX,TG Therapeutics is about to announce its earnings — here's what Wall Street expects,8/7/2022 3:01:13 PM
TGTX,TG Therapeutics Q2 2022 Earnings Preview,8/5/2022 5:48:04 PM
TGTX,TG THERAPEUTICS INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against TG Therapeutics Inc. (NASDAQ: TGTX); Lead Plaintiff Deadline is September 16 2022,8/4/2022 10:49:00 PM
TGTX,"ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTX",7/30/2022 4:16:00 AM
TGTX,"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTX",7/22/2022 9:56:00 PM
TGTX,5 Analysts Have This to Say About TG Therapeutics,6/13/2022 3:12:38 PM
TGTX,"Pre-market Movers: SYM, FNCH, SGLY, SCKT, FRGE… ",6/9/2022 1:35:42 PM
TGTX,"TGTX, MULN and EFOI among pre market gainers",6/3/2022 12:49:17 PM
TGTX,TG Therapeutics slips as FDA withdraws approval for cancer drug,6/1/2022 2:08:56 PM
TGTX,TG Therapeutics : FDA Extends PDUFA Date For Ublituximab To Treat Patients With RMS ,5/31/2022 1:52:45 PM
TGTX,TG Therapeutics initiated at BofA with a bearish view on multiple sclerosis drug,5/20/2022 4:40:46 PM
TGTX,FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs,4/21/2022 9:08:10 PM
TGTX,Expert Ratings for TG Therapeutics,4/19/2022 10:01:05 PM
TGTX,"Despite Price Cut, HC Wainwright Keeps Buy Rating On TG Therapeutics - Read Why",4/18/2022 9:34:54 PM
TGTX,"The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More",4/17/2022 8:31:32 PM
TGTX,Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates,4/1/2022 9:16:51 PM
TGTX,Biotech Stocks Facing FDA Decision In April 2022 ,3/28/2022 7:31:43 AM
TGTX,FDA Pushes TG Therapeutics' Ublituximab / Ukoniq Combo Therapy Applications In Blood Cancer Settings,3/3/2022 5:27:59 PM
TGTX,Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates,3/2/2022 1:08:52 PM
TGTX,"TG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08M",3/1/2022 12:35:00 PM
TGTX,TG Therapeutics Q4 2021 Earnings Preview,2/28/2022 5:12:58 PM
TGTX,TG Therapeutics slips on concerns over FDA probe on cancer medicine,2/3/2022 3:22:22 PM
TGTX,52 Biggest Movers From Friday,1/31/2022 11:03:54 AM
TGTX,TG Therapeutics rebounds as B. Riley defends after selloff,1/28/2022 4:13:32 PM
TGTX,TG Therapeutics Falls 30% As CEO Discloses Partial Clinical Hold On Blood Cancer Trials,1/27/2022 6:30:35 PM
TGTX,Where TG Therapeutics Stands With Analysts,1/24/2022 6:02:22 PM
TGTX,63 Biggest Movers From Friday,12/20/2021 10:55:33 AM
TGTX,"TG Therapeutics presents ublituximab, ukoniq combo data in B-cell malignancies at ASH2021",12/13/2021 1:23:44 PM
TGTX,"Adagio, Vir among weekly healthcare gainers; Novavax slips ahead of more data on Omicron",12/5/2021 2:00:31 AM
TGTX,TG Therapeutics price target lowered at Wainwright following FDA meeting on cancer therapy,12/1/2021 4:34:43 PM
TGTX,Mid-Afternoon Market Update: Dow Dips 500 Points; ImmunoGen Shares Spike Higher,11/30/2021 8:31:50 PM
TGTX,"Pharma dealmaking, Cassava Sciences, Clover Health among healthcare headliners this week",11/21/2021 2:00:42 AM
TGTX,70 Biggest Movers From Yesterday,11/16/2021 10:43:28 AM
TGTX,41 Stocks Moving In Monday's Mid-Day Session,11/15/2021 6:08:06 PM
TGTX,"TG Therapeutics EPS misses by $0.10, misses on revenue",11/4/2021 11:04:52 AM
TGTX,Notable earnings before Thursday's open,11/3/2021 3:55:55 PM
TGTX,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight",9/19/2021 3:46:51 PM
TGTX,"The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold",9/17/2021 1:36:08 PM
TGTX,"The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs",9/12/2021 10:04:17 PM
TGTX,TG Therapeutics' pullback is a buying opportunity - Cantor,8/3/2021 2:47:48 PM
TGTX,TG Therapeutics Stock Plunged As H.C. Wainwright Cuts Target Price After Disappointing Q2,8/2/2021 9:17:57 PM
TGTX,TG Therapeutics earnings preview: what Wall Street is expecting,7/31/2021 3:01:21 PM
TGTX,"Biotech M&A may heat up with potential targets Horizon Therapeutics, Arrowhead Pharma, analyst says",7/11/2021 1:00:00 PM
TGTX,4 Stocks to Boost Your Portfolio (In an Unintuitive Way),6/21/2021 9:19:23 PM
TGTX,TG Therapeutics reports preclinical data evaluating TG-1701 in B-cell malignancies,6/18/2021 12:20:28 PM
TGTX,TG Therapeutics reports TG-1701 data in blood cancers at EHA 2021,6/11/2021 12:01:26 PM
TGTX,"The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes",5/31/2021 5:06:35 PM
TGTX,China education stocks and Shake Shack among premarket gainers,5/25/2021 12:23:39 PM
TGTX,Biotech M&A could soon pick up following slow 2021 start - Jefferies,5/23/2021 7:25:39 PM
TGTX,"TG Therapeutics posts Q1 results, gives cash position update",5/10/2021 11:39:43 AM
TGTX,"The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings",5/9/2021 4:20:33 PM
TGTX,TG Therapeutics earnings: here's what Wall Street expects,5/8/2021 3:01:29 PM
TGTX,TG Therapeutics expands manufacturing of ublituximab,4/26/2021 4:40:06 AM
TGTX,TG Therapeutics launches late-stage study of triple combination of Ukoniq,4/21/2021 11:31:06 AM
TGTX,"Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021",4/20/2021 4:04:33 PM
TGTX,TG Therapeutics price target upped at Cantor citing the potential of MS therapy,4/19/2021 6:40:19 PM
TGTX,TG Therapeutics' ublituximab shows promising action in multiple sclerosis,4/16/2021 11:43:05 AM
TGTX,The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight,4/10/2021 3:20:43 PM
TGTX,TG Therapeutics completes rolling submission of ublituximab combo BLA as leukemia treatment,3/29/2021 12:03:48 PM
TGTX,"TG Therapeutics EPS misses by $0.13, beats on revenue",3/2/2021 12:06:25 PM
TGTX,TG Therapeutics reports final data from ublituximab combo in blood cancer,2/23/2021 1:10:40 PM
TGTX,TG Therapeutics climbs after FDA approval for Ukoniq,2/5/2021 6:51:48 PM
TGTX,Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates,1/31/2021 11:22:18 AM
TGTX,TG Therapeutics to Participate in the B. Riley Securities Oncology Investor Conference,1/15/2021 1:00:00 PM
TGTX,"The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates",1/14/2021 1:56:59 PM
TGTX,TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference,1/8/2021 1:00:00 PM
TGTX,Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run? ,12/28/2020 3:33:59 AM
TGTX,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",12/23/2020 2:30:53 PM
TGTX,Stocks That Hit 52-Week Highs On Tuesday,12/22/2020 4:30:53 PM
TGTX,Stock Alert: TG Therapeutics Rises To New 52-week High ,12/15/2020 4:06:29 PM
TGTX,TG Therapeutics Announces Proposed Public Offering of Common Stock,12/14/2020 1:30:53 PM
TGTX,"SLS, ONCY, BTU and GENE among midday movers",12/10/2020 5:40:28 PM
TGTX,TG Therapeutics surges after favorable data from two pivotal trials,12/8/2020 6:11:28 PM
TGTX,TG Therapeutics Announces Pivotal Data from the UNITY-CLL and UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual Meeting,12/7/2020 4:15:00 PM
TGTX,TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition,12/3/2020 1:00:00 PM
TGTX,TG Therapeutics Announces Publication of Phase 2 Data Evaluating Umbralisib in Patients with Chronic Lymphocytic Leukemia Who Are Intolerant to Prior BTK or PI3K Inhibitor Therapy in Blood,12/2/2020 1:15:00 PM
TGTX,TG Therapeutics commences rolling U.S. application for doublet therapy for CLL,12/1/2020 1:23:48 PM
TGTX,TG Therapeutics to Participate in the 3rd Annual Evercore ISI HealthCONx Conference,11/30/2020 1:00:00 PM
TGTX,TG Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference,11/13/2020 1:00:00 PM
TGTX,TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results,11/9/2020 10:15:00 PM
TGTX,TG Therapeutics Highlights Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting ,11/4/2020 5:45:00 PM
TGTX,TG Therapeutics Announces Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition,11/2/2020 1:00:00 PM
TGTX,TG Therapeutics Announces Fast Track Designation Granted by the FDA to Ublituximab in Combination with Umbralisib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia,10/21/2020 1:30:10 PM
TGTX,TG Therapeutics to Present at Upcoming Investor Conferences,9/9/2020 3:17:16 PM
TGTX,TG Therapeutics Announces FDA Acceptance of New Drug Application for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma and Follicular Lymphoma,8/13/2020 1:00:10 PM
TGTX,TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results,8/10/2020 1:00:10 PM
TGTX,Here's what Wall Street expects from TG Therapeutics's earnings,8/9/2020 3:01:32 PM
TGTX,TG Therapeutics to Host Conference Call on Second Quarter 2020 Financial Results and Business Update,8/6/2020 1:30:10 PM
TGTX,TG Therapeutics Announces Publication in Blood Advances Describing Unique Immunomodulatory Effects on CLL T cells by Umbralisib,7/8/2020 1:00:10 PM
TGTX,TG Therapeutics Announces Preclinical Data Presentation at the 2020 American Association for Cancer Research Annual Meeting,6/22/2020 3:00:10 PM
TGTX,TG Therapeutics Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone...,6/17/2020 1:00:10 PM
TGTX,TG Therapeutics to Present at the Raymond James 2020 Human Health Innovation Conference,6/16/2020 1:00:10 PM
TGTX,TG Therapeutics Announces Data Presentations at the 25th European Hematology Association (EHA) Annual Congress,6/12/2020 1:00:10 PM
TGTX,TG Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference,6/9/2020 1:00:10 PM
TGTX,TG Therapeutics to Present at the Jefferies 2020 Healthcare Conference,6/2/2020 1:00:10 PM
TGTX,TG Therapeutics Announces Final Results of the GENUINE Phase 3 Study Evaluating Ublituximab plus Ibrutinib in Previously Treated High-Risk Chronic Lymphocytic Leukemia at the 56th American Society...,5/29/2020 2:15:10 PM
TGTX,3 Small-Cap Stocks Ready for Big Growth,5/28/2020 5:57:55 PM
TGTX,TG Therapeutics Announces Preclinical Data Presentation at the Upcoming American Association for Cancer Research Annual Meeting,5/15/2020 1:00:10 PM
TGTX,TG Therapeutics Announces Proposed Public Offering of Common Stock,5/14/2020 10:01:45 PM
TGTX,TG Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results,5/11/2020 10:00:10 PM
TGTX,"TG Therapeutics Strengthens Executive Team with the Addition of Owen A. O’Connor, MD, PhD, as Chief Scientific Officer",5/8/2020 1:00:10 PM
TGTX,TG Therapeutics Raises Approximately $60 Million in Gross Proceeds Through its At-the-Market Facility,5/6/2020 1:00:10 PM
TGTX,"PTLA, TGTX, NCLH and HTZ among midday movers",5/5/2020 4:42:35 PM
TGTX,TG Therapeutics Announces Publication of Ublituximab Phase 2 Clinical Trial Results in Multiple Sclerosis Journal,5/1/2020 1:30:10 PM
TGTX,"TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD",4/29/2020 1:20:10 PM
TGTX,TG Therapeutics Announces Data Presentations at the Upcoming American Academy of Neurology 72nd Annual Meeting,3/9/2020 1:00:00 PM
TGTX,TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Follicular Lymphoma,3/5/2020 5:00:00 PM
TGTX,"INO On Track, MITO All Powered Up, TGTX Braces For Busy Year, COVID-19 Update ",3/4/2020 7:29:00 AM
TGTX,TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2019 Financial Results,3/3/2020 1:00:00 PM
TGTX,TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2019 Financial Results and Business Update,2/28/2020 1:30:00 PM
TGTX,TG Therapeutics Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone...,1/16/2020 1:30:00 PM
TGTX,TG Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference,1/10/2020 1:30:00 PM
TGTX,TG Therapeutics Announces $50.0 Million Registered Direct Public Offering of Common Stock to a Single Institutional Investor,12/23/2019 1:30:00 PM
TGTX,"TG Therapeutics Announces Phase I Data Presentation for TG-1701, a Once-Daily BTK Inhibitor, as a Single Agent and in Triple Combination with Ublituximab and Umbralisib (U2), at the 61st American...",12/9/2019 2:00:00 PM
TGTX,"TG Therapeutics Announces Oral Presentation of Umbralisib, Ublituximab and Venetoclax Triple Combination Phase I/II Data in Relapsed/Refractory CLL at the 61st American Society of Hematology Annual...",12/8/2019 3:00:00 PM
TGTX,TG Therapeutics Recaps Schedule of Triple Therapy Data Presentations at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition,12/6/2019 1:30:10 PM
TGTX,TG Therapeutics to Present at the Jefferies London Healthcare Conference,11/18/2019 1:30:00 PM
TGTX,TG Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results,11/12/2019 1:34:26 PM
TGTX,TG Therapeutics to Host Conference Call on Third Quarter 2019 Financial Results and Business Update,11/8/2019 1:30:00 PM
TGTX,TG Therapeutics Announces Triple Combination Data Presentations at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition,11/6/2019 3:15:00 PM
TGTX,"Top 6 Gainers In Healthcare Sector Today (CRVS, CLVS, TGTX…) ",10/29/2019 2:42:52 AM
TGTX,TG Therapeutics Announces Positive Results from the UNITY-NHL Phase 2b Pivotal Trial Evaluating Umbralisib Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma,10/28/2019 12:00:05 PM
TGTX,TG Therapeutics Announces Final Long-Term Results from the Phase 3 GENUINE Study Demonstrated that Ublituximab in Combination with Ibrutinib Improved Progression-Free Survival in Patients with...,10/24/2019 1:30:05 PM
TGTX,TG Therapeutics to Present at the 2019 Cantor Global Healthcare Conference,10/2/2019 1:30:00 PM
TGTX,TG Therapeutics Announces Publication of Clinical Data from the Phase I/Ib Combination Trial of Ublituximab and Umbralisib (“U2”) in Blood,9/30/2019 1:30:00 PM
TGTX,TG Therapeutics Announces Data Presentations at the XVIII International Workshop on Chronic Lymphocytic Leukemia (iwCLL),9/23/2019 1:30:00 PM
TGTX,TG Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference ,9/20/2019 1:30:00 PM
TGTX,TG Therapeutics Presents Data for Ublituximab at the 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS),9/12/2019 1:30:00 PM
TGTX,TG Therapeutics Announces Data Presentations at the Upcoming 35th Annual Congress of ECTRIMS ,8/29/2019 1:30:00 PM
TGTX,"TG Therapeutics Mourns the Loss of Board Member, Mark Schoenebaum, MD",8/26/2019 6:00:00 PM
TGTX,TG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results,8/9/2019 1:30:00 PM
TGTX,TG Therapeutics is about to announce its earnings — here's what to expect,8/8/2019 3:02:58 PM
TGTX,TG Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results and Business Update,8/7/2019 10:05:00 PM
TGTX,TG Therapeutics Announces Presentation of Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis During an Oral Session at the 5th Congress of the...,7/2/2019 1:30:00 PM
TGTX,"5 Top Gainers In Healthcare Sector (DOVA, ATOS, ZGNX...) ",6/28/2019 3:43:55 AM
TGTX,TG Therapeutics Announces Data Presentations at the 15th International Conference on Malignant Lymphoma,6/20/2019 3:05:00 PM
TGTX,TG Therapeutics to Present at the Raymond James Life Sciences and MedTech Conference,6/18/2019 1:30:00 PM
TGTX,"TG Therapeutics Presents Preclinical Data for TG-1801, a First-in-Class Anti-CD47/CD19 Bispecific Antibody, at the 24th European Hematology Association Annual Congress",6/17/2019 1:30:00 PM
TGTX,TG Therapeutics Confirms Registration Path for Umbralisib in Marginal Zone Lymphoma Following FDA Meeting,6/11/2019 1:58:01 PM
TGTX,TG Therapeutics Presents Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 55th American Society of Clinical...,6/4/2019 10:02:22 PM
TGTX,TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings,5/16/2019 1:30:00 PM
TGTX,What Wall Street expects from TG Therapeutics's earnings,5/10/2019 3:01:42 PM
TGTX,TG Therapeutics to Host Conference Call on First Quarter 2019 Financial Results and Business Update,5/9/2019 1:30:00 PM
TGTX,TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at the American Academy of Neurology 71st Annual Meeting,5/7/2019 3:00:00 PM
TGTX,TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Marginal Zone Lymphoma,4/15/2019 1:30:00 PM
TGTX,TG Therapeutics to Present at the 18th Annual Needham Healthcare Conference,4/5/2019 1:30:00 PM
TGTX,TG Therapeutics Reports Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 2019 AACR Annual Meeting,4/1/2019 2:30:00 PM
TGTX,TG Therapeutics to Present Interim Data from the UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the Upcoming 2019 AACR Annual Meeting,3/29/2019 9:00:00 PM
TGTX,"TG Therapeutics, Inc. Announces Data Presentation at the Upcoming American Academy of Neurology 71st Annual Meeting",3/12/2019 1:00:00 PM
TGTX,TG Therapeutics to Present at the Cowen 39th Annual Health Care Conference,3/11/2019 8:26:45 AM
TGTX,TG Therapeutics Announces Positive Data Safety Monitoring Board Reviews of UNITY-CLL and UNITY-NHL Clinical Trials,3/8/2019 1:30:00 PM
TGTX,TG Therapeutics Announces Approximately $85 million in Equity and Debt Financings,3/1/2019 3:00:00 PM
TGTX,TG Therapeutics Announces Proposed Public Offering of Common Stock and Closing of $60.0 Million Venture Debt Financing,2/28/2019 10:01:00 PM
TGTX,"TG Therapeutics Announces Initiation of Phase I First-in-Human Clinical Trial of its Anti-CD47/CD19 Bispecific Antibody, TG-1801, in Patients with Relapsed or Refractory B-cell Lymphoma",2/26/2019 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Data Presentation at the Upcoming Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Annual Meeting",2/22/2019 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Publication of Clinical Data from the Phase I Triple Therapy Combination Trial of Ublituximab, Umbralisib, and Ibrutinib in The Lancet Haematology",1/30/2019 1:30:00 PM
TGTX,TG Therapeutics Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Umbralisib for the Treatment of Marginal Zone Lymphoma,1/22/2019 1:30:00 PM
TGTX,"TG Therapeutics, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference",1/7/2019 1:30:00 PM
TGTX,"TG Therapeutics, Inc. and Dana-Farber Cancer Institute Announce Publication of Clinical Data from the Phase 1/1b Trial of Umbralisib in Combination with Ibrutinib in Lancet Haematology",12/17/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Follow-Up Data from the Triple Combination of Ublituximab, Umbralisib, and Bendamustine in Patients with DLBCL and FL at 60th American Society of Hematology Annual...",12/4/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Oral Presentation of Follow-Up Data from the Triple Combination of Ublituximab, Umbralisib, and Pembrolizumab in Patients with Relapsed/Refractory CLL and Richter’s...",12/3/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Recaps Triple Therapy Data Presentations at the Upcoming 60th American Society of Hematology Annual Meeting and Exposition",11/30/2018 1:30:00 PM
TGTX,"TG Therapeutics Announces Phase I Study of Novel BTK inhibitor, TG-1701, in Patients with Relapsed or Refractory B-cell Malignancies is Open for Enrollment",11/13/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2018 Financial Results",11/9/2018 1:30:00 PM
TGTX,Here's what Wall Street expects from TG Therapeutics's earnings,11/8/2018 3:02:25 PM
TGTX,"TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2018 Financial Results and Business Update",11/7/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Triple Therapy Data Presentations at the Upcoming 60th American Society of Hematology Annual Meeting and Exposition",11/1/2018 2:46:51 PM
TGTX,"TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Presentation at the 34th Congress of ECTRIMS",10/11/2018 5:00:00 PM
TGTX,"TG Therapeutics, Inc. Highlights Schedule of Events at the Upcoming 34th Congress of ECTRIMS",10/8/2018 1:30:00 PM
TGTX,"Week Ahead In Pharmaceuticals: 5 Stocks To Watch (OMER, BOLD, XLRN...) ",9/29/2018 7:32:19 AM
TGTX,"TG Therapeutics, Inc. to Present at Upcoming Investor Conferences",9/28/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Accepted for Oral Presentation at the Upcoming 34th Congress of ECTRIMS",9/26/2018 2:00:00 PM
TGTX,TG Therapeutics Announces Update Regarding UNITY-CLL Phase 3 Trial,9/25/2018 1:00:00 PM
TGTX,"TG Therapeutics, Inc. Provides Business Update and Reports Second Quarter 2018 Financial Results",8/7/2018 10:00:00 PM
TGTX,"TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2018 Financial Results and Business Update",8/6/2018 1:30:00 PM
TGTX,TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody,6/20/2018 1:30:00 PM
TGTX,"CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today ",6/19/2018 7:52:08 AM
TGTX,"TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab in Patients with Multiple Sclerosis at the 4th Congress of the European Academy of Neurology",6/18/2018 6:00:00 PM
TGTX,"TG Therapeutics, Inc. Announces Clinical and Preclinical Data Presentations at the 23rd Congress of the European Hematology Association",6/15/2018 3:17:49 PM
TGTX,"TG Therapeutics, Inc. to Present at the Jefferies 2018 Global Healthcare Conference",6/5/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology",6/4/2018 3:00:00 PM
TGTX,"TG Therapeutics, Inc. Recaps Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association",6/1/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association",5/17/2018 3:10:00 PM
TGTX,BRIEF-TG Therapeutics Reports Qtrly Loss Per Share Of $0.59,5/8/2018 1:37:24 PM
TGTX,"TG Therapeutics, Inc. to Host Conference Call on First Quarter 2018 Financial Results and Business UpdateInvestor Conference Call to be held Tuesday, May 8, 2018 at 8:30am ET",5/4/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the American Academy of Neurology 70th Annual...",4/24/2018 2:06:18 PM
TGTX,"TG Therapeutics, Inc. Announces Preclinical Data Presentation on the Company’s BET Inhibitor, TG-1601, at the 2018 American Association for Cancer Research (AACR) Annual Meeting",4/18/2018 3:00:00 PM
TGTX,"TG Therapeutics, Inc. to Present at the Needham 17th Annual Healthcare ConferencePresentation scheduled for Wednesday, March 28, 2018 at 4:00pm ET",3/26/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting",3/15/2018 12:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2017 Financial Results and Business UpdateInvestor conference call to be held today, Thursday March 8, 2018 at 8:30am ET  ",3/8/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2017 Financial Results and Business UpdateInvestor Conference Call to be held Thursday, March 8, 2018 at 8:30am ET  ",3/6/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. to Present at Upcoming Investor Conferences",3/2/2018 1:30:00 PM
TGTX,"ANTH Awaits RESULT In Mar., HAIR Grows, NITE Shines, TRXC On Must-watch List ",2/22/2018 3:04:14 AM
TGTX,"TG Therapeutics, Inc. Announces Publication of Clinical Data from the Phase 1 First-in-Human Trial of Umbralisib in The Lancet Oncology",2/21/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the Third Annual ACTRIMS Forum 2018",2/2/2018 12:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Data Presentation at the Upcoming Third Annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2018",1/24/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. to Present at the 36th Annual J.P. Morgan Healthcare ConferencePresentation Scheduled for Thursday, January 11, 2018 at 7:30am PT",1/8/2018 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Preclinical & Clinical Data Presentations at the 59th American Society of Hematology Annual Meeting",12/11/2017 1:00:00 PM
TGTX,"TG Therapeutics, Inc. Recaps Data Presentations at the Upcoming 59th American Society of Hematology Annual MeetingInvestor and Analyst Reception to be Held on Sunday December 10, 2017 at 8:",12/8/2017 2:06:07 PM
TGTX,TG Therapeutics Announces Initiation of National Cancer Institute/SWOG-Sponsored Randomized Phase II Trial in Follicular LymphomaTGR-1202 (umbralisib) selected as the PI3K Delta inhibitor to be...,11/27/2017 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2017 Financial ResultsInvestor Conference Call to be Held Today, Wednesday, November 8, 2017 at 8:30am ET",11/8/2017 1:30:00 PM
TGTX,"TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2017 Financial Results and Business UpdateInvestor Conference Call to be held Wednesday, November 8, 2017 at 8:30am ET",11/6/2017 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 59th American Society of Hematology Annual MeetingInvestor and Analyst Reception to be Held on Sunday December 10, 2017 at 8:",11/1/2017 2:30:00 PM
TGTX,"TG Therapeutics, Inc. to Host Post ECTRIMS-ACTRIMS Conference Call to Review Data Presented on TG-1101 (ublituximab) in Multiple Sclerosis",10/31/2017 12:30:00 PM
TGTX,"FDA To Rule On Elagolix In Q2, More Light From CELG's RADIANCE, TGTX On Watch ",10/30/2017 4:00:28 AM
TGTX,"TG Therapeutics, Inc. Announces Additional Updated Results from the Ongoing Phase 2 Study of TG-1101 (ublituximab) in Patients with Multiple Sclerosis at the 7th Joint ECTRIMS – ACTRIMS Meeting",10/27/2017 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of TG-1101 (ublituximab) in Patients with Multiple Sclerosis at the 7th Joint ECTRIMS – ACTRIMS Meeting",10/26/2017 1:30:00 PM
TGTX,TG Therapeutics Announces Completion of Full Enrollment in the UNITY-CLL Phase 3 Trial,10/16/2017 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces Advancement of its Anti-PD-L1 Monoclonal Antibody into Clinical Development",10/5/2017 1:30:00 PM
TGTX,TG Therapeutics Announces TGR-1202 (umbralisib) Selected For Grant from the National Multiple Sclerosis Society to Support the Development of TGR-1202 as an Oral B-cell Targeted Treatment Option in...,9/29/2017 1:30:00 PM
TGTX,"TG Therapeutics, Inc. to Present at Upcoming Investor Conferences",9/21/2017 1:30:00 PM
TGTX,"TG Therapeutics, Inc. Announces the Phase 3 ULTIMATE Trials Evaluating TG-1101 in Patients with Multiple Sclerosis Are Now Open for Enrollment",9/15/2017 1:30:00 PM
TGTX,"Breakfast Technical Briefing on Biotech Stocks -- CytRx, Keryx Biopharma, TG Therapeutics, and ZIOPHARM Oncology",6/22/2017 12:10:00 PM
TGTX,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar ",6/15/2017 8:26:54 AM
TGTX,"Investors: Covered Call reports for Alcoa, bluebird bio Inc., Juno Therapeutics Inc, TG Therapeutics and XPO Logistics Inc include trade ideas that offer returns of 25% or more!",6/8/2017 3:31:00 PM
TGTX,"AMGN Finds New Use For Old Drug, NLNK Disappointed, ECYT Cuts Workforce ",6/5/2017 8:42:55 AM
TGTX,"MRK's Keytruda Scores Another FDA Nod, NBIX Disappoints, SBPH Achieves It ",5/24/2017 7:25:21 AM
TGTX,"How These Biotech Stocks are Faring? -- ACADIA Pharma, Alexion Pharma, TG Therapeutics, and Esperion Therapeutics",4/24/2017 1:00:00 PM
TGTX,Company Spotlight: TG Therapeutics Inc. ,3/10/2017 7:18:20 AM
TGTX,"DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Investors It Has Filed a Class Action Lawsuit Against TG Therapeutics, Inc. and Announces a Lead Plaintiff Deadline of March 7, 2017 - TGTX",3/7/2017 4:03:00 PM
